Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Product Detail

Biomarkers for Alzheimer's Disease Drug Development

Perneczky, Robert
Biomarkers for Alzheimers Disease Drug Development Cover Image
Pricing & Availability
Available: 0
List Price:$139.99

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version
Book Information
Edition: 1st
Publisher: Humana Press
ISBN: 1-4939-7703-2 (1493977032)
ISBN-13: 978-1-4939-7703-1 (9781493977031)
Binding: Hardcover
Copyright: 2019
Publish Date: 03/18
Volume: 1750
Weight: 1.97 Lbs.
Pages: 372
Subject Class: PRM (Pharmacology)
Return Policy: Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Contributing Authors: View
 
Class Specifications
ISSN Series: Methods in Molecular Biology
Discipline: Geriatrics
Subject Definition: Alzheimer Disease; Biomarkers, Pharmcological
NLM Class: WT 155
LC Class: RC523
Abstract: This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer's disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer's disease, cutting-edge developments in neuropathology and their relevance for Alzheimer's disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Biomarkers for Alzheimers Disease Drug Development aims to ensure successful results in the further study of this vital field.

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement